Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 84476 - 84500 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Tretinoin	Approved Investigational Nutraceutical	VIP	7432	downregulated	Tretinoin results in decreased expression of VIP mRNA	6q25.2	A24453
Tretinoin	Approved Investigational Nutraceutical	VIPR1	7433	downregulated	Tretinoin results in decreased expression of VIPR1 mRNA	3p22.1	A24456
Tretinoin	Approved Investigational Nutraceutical	VLDLR	7436	upregulated	Tretinoin results in increased expression of VLDLR mRNA	9p24.2	A24454 A24456
Tretinoin	Approved Investigational Nutraceutical	VLDLR-AS1	401491	upregulated	Tretinoin results in increased expression of VLDLR-AS1 mRNA	9p24.2	A24456
Tretinoin	Approved Investigational Nutraceutical	VPS13B	157680	upregulated	Tretinoin results in increased expression of VPS13B mRNA	8q22.2	A24453
Tretinoin	Approved Investigational Nutraceutical	VPS13C	54832	upregulated	Tretinoin results in increased expression of VPS13C mRNA	15q22.2	A24454
Tretinoin	Approved Investigational Nutraceutical	VPS13D	55187	upregulated	Tretinoin results in increased expression of VPS13D mRNA	1p36.22-p36.21	A24453
Tretinoin	Approved Investigational Nutraceutical	VRK2	7444	downregulated	Tretinoin results in decreased expression of VRK2 mRNA	2p16.1	A24376
Tretinoin	Approved Investigational Nutraceutical	VRTN	55237	downregulated	Tretinoin results in decreased expression of VRTN mRNA	14q24.3	A24454
Tretinoin	Approved Investigational Nutraceutical	VSIR	64115	upregulated	Tretinoin results in increased expression of VSIR mRNA	10q22.1	A24454 A24456
Tretinoin	Approved Investigational Nutraceutical	VSNL1	7447	downregulated	Tretinoin results in decreased expression of VSNL1 mRNA	2p24.2	A24454 A24453
Tretinoin	Approved Investigational Nutraceutical	VSTM2A	222008	upregulated	Tretinoin results in increased expression of VSTM2A mRNA	7p11.2	A24453
Tretinoin	Approved Investigational Nutraceutical	VTCN1	79679	upregulated	Tretinoin results in increased expression of VTCN1 mRNA	1p13.1-p12	A24455 A24454
Tretinoin	Approved Investigational Nutraceutical	WAC	51322	upregulated	Tretinoin results in increased expression of WAC mRNA	10p12.1	A24453
Tretinoin	Approved Investigational Nutraceutical	WARS	7453	upregulated	Tretinoin results in increased expression of WARS mRNA	14q32.2	A24376 A24466
Tretinoin	Approved Investigational Nutraceutical	WAS	7454	upregulated	Tretinoin results in increased expression of WAS mRNA	Xp11.23	A24457
Tretinoin	Approved Investigational Nutraceutical	WASF2	10163	downregulated	Tretinoin results in decreased expression of WASF2 mRNA	1p36.11	A24453
Tretinoin	Approved Investigational Nutraceutical	WASF3	10810	downregulated	Tretinoin results in decreased expression of WASF3 mRNA	13q12.13	A24454
Tretinoin	Approved Investigational Nutraceutical	WBP1	23559	upregulated	Tretinoin results in increased expression of WBP1 mRNA	2p13.1	A24453
Tretinoin	Approved Investigational Nutraceutical	WDHD1	11169	downregulated	Tretinoin results in decreased expression of WDHD1 mRNA	14q22.2-q22.3	A24453
Tretinoin	Approved Investigational Nutraceutical	WDR12	55759	downregulated	Tretinoin results in decreased expression of WDR12 mRNA	2q33.2	A24453
Tretinoin	Approved Investigational Nutraceutical	WDR18	57418	downregulated	Tretinoin results in decreased expression of WDR18 mRNA	19p13.3	A20711
Tretinoin	Approved Investigational Nutraceutical	WDR34	89891	downregulated	Tretinoin results in decreased expression of WDR34 mRNA	9q34.11	A24453
Tretinoin	Approved Investigational Nutraceutical	WDR4	10785	downregulated	Tretinoin results in decreased expression of WDR4 mRNA	21q22.3	A24453
Tretinoin	Approved Investigational Nutraceutical	WDR72	256764	upregulated	Tretinoin results in increased expression of WDR72 mRNA	15q21.3	A24454

Displaying entries 84476 - 84500 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability